Total Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$220K Buy
+1,178
New +$202K 0.02% 80
2025
Q3
Sell
-1,177
Closed -$149K 429
2025
Q2
$149K Buy
+1,177
New +$144K 0.02% 96
2024
Q2
Sell
-1,958
Closed -$269K 71
2024
Q1
$269K Buy
1,958
+1
+0.1% +$137 0.03% 57
2023
Q4
$266K Buy
1,957
+2
+0.1% +$244 0.03% 58
2023
Q3
$239K Hold
1,955
0.03% 59
2023
Q2
$248K Hold
1,955
0.03% 60
2023
Q1
$252K Sell
1,955
-430
-18% -$56.3K 0.05% 53
2022
Q4
$313K Sell
2,385
-241
-9% -$31.1K 0.08% 43
2022
Q3
$307K Sell
2,626
-17
-0.6% -$2.11K 0.06% 41
2022
Q2
$311K Sell
2,643
-66
-2% -$7.83K 0.06% 47
2022
Q1
$353K Buy
2,709
+1
+0% +$130 0.07% 49
2021
Q4
$413K Sell
2,708
-2,236
-45% -$346K 0.07% 50
2021
Q3
$799K Sell
4,944
-325,578
-99% -$54.8M 0.2% 25
2021
Q2
$54.1M Buy
+330,522
New +$50.9M 9.34% 5
2021
Q1
Sell
-332,655
Closed -$50.4M 55
2020
Q4
$50.4M Buy
332,655
+1,476
+0.4% +$211K 9.77% 4
2020
Q3
$43.3M Buy
331,179
+33,973
+11% +$4.61M 12.5% 2
2020
Q2
$40.6M Buy
+297,206
New +$37.9M 14.18% 3

Other funds holding IBB

Total Investment Management's IBB Position: Q2 2026 in Review

Total Investment Management opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 1,178 shares worth $220K. The stake represents 0.02% of the portfolio and ranks #80 among its holdings. This is a return to the name: Total Investment Management previously reported a position in IBB as recently as Q2 2025.

Total Investment Management first reported a position in IBB in Q2 2020 and has held it in 17 quarters since. The position peaked at $54.1M in Q2 2021. 451 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Total Investment Management held 1,178 shares of iShares Biotechnology ETF worth $220K as of Q2 2026.
  • iShares Biotechnology ETF was a new Total Investment Management position in Q2 2026.
  • iShares Biotechnology ETF made up 0.02% of Total Investment Management's portfolio in Q2 2026, its #80 holding.
  • Total Investment Management first reported a position in iShares Biotechnology ETF in Q2 2020 and has held it in 17 quarters since.
  • Total Investment Management's iShares Biotechnology ETF position peaked at $54.1M in Q2 2021.
  • 451 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Total Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.